by Dr Robbins | Jan 23, 2013 | Headache Drugs
U.S. Specialty drugmaker Allergan has announced that it will buy MAP Pharmaceuticals, a purchase that will intensify Allergan’s presence in medicines for the treatment of adult migraines. Allergan manufactures Botox, which in the last few years has received...
by Dr Robbins | Jan 18, 2013 | Headache Drugs
The pharmaceutical company NuPathe Inc. has announced that the FDA has approved Zecuity for the acute treatment of migraine with or without aura in adults. A single-use, battery-powered patch, Zecuity delivers sumatriptan through the skin. The patch provides relief...
by Dr Robbins | Jan 2, 2013 | Headache Drugs
The generic equivalent of Merck’s Maxalt tablets, Rizatriptan Benzoate, indicated for the acute treatment of migraine has just been approved by the Federal Drug Administration. India based Aurobindo Pharma has received final approval to manufacture and market...
by Dr Robbins | Dec 21, 2012 | Headache Drugs
A device, which delivers low-dose sumatriptan through the nose for headache relief has shown promise in it’s phase III study according to Optinose US Inc. According to a company press release, patients began to feel headache relief within 15 minutes of using the...
by Dr Robbins | Dec 18, 2012 | Headache Drugs
It seems that many people resort to Twitter and Google when they are dealing with a headache. And their searches and tweets are helping researchers learn more about how and when migraine and headache impact their lives. This study, which was conducted between January...
